Canada Life’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-74,927
| Closed | -$3.16M | – | 2252 |
|
|
2023
Q2 | $3.16M | Sell |
74,927
-8,222
| -10% | -$332K | 0.01% | 951 |
|
|
2023
Q1 | $2.96M | Sell |
83,149
-640
| -0.8% | -$23.2K | 0.01% | 1027 |
|
|
2022
Q4 | $3.08M | Buy |
83,789
+14,414
| +21% | +$570K | 0.01% | 1003 |
|
|
2022
Q3 | $3.27M | Buy |
69,375
+6,325
| +10% | +$409K | 0.01% | 885 |
|
|
2022
Q2 | $4.52M | Buy |
63,050
+6,386
| +11% | +$467K | 0.01% | 737 |
|
|
2022
Q1 | $4.72M | Buy |
56,664
+4,203
| +8% | +$356K | 0.01% | 777 |
|
|
2021
Q4 | $5.38M | Buy |
52,461
+3,937
| +8% | +$378K | 0.01% | 729 |
|
|
2021
Q3 | $4.28M | Buy |
48,524
+9,491
| +24% | +$859K | 0.01% | 773 |
|
|
2021
Q2 | $3.49M | Buy |
39,033
+8,199
| +27% | +$693K | 0.01% | 830 |
|
|
2021
Q1 | $2.34M | Sell |
30,834
-32
| -0.1% | -$2.41K | 0.01% | 1040 |
|
|
2020
Q4 | $2.1M | Sell |
30,866
-1,804
| -6% | -$112K | ﹤0.01% | 1104 |
|
|
2020
Q3 | $1.74M | Buy |
32,670
+1,898
| +6% | +$113K | ﹤0.01% | 1138 |
|
|
2020
Q2 | $1.79M | Sell |
30,772
-1,751
| -5% | -$94.1K | ﹤0.01% | 1133 |
|
|
2020
Q1 | $1.28M | Buy |
32,523
+2,259
| +7% | +$132K | ﹤0.01% | 1169 |
|
|
2019
Q4 | $1.79M | Sell |
30,264
-1,042
| -3% | -$56K | ﹤0.01% | 1200 |
|
|
2019
Q3 | $1.67M | Sell |
31,306
-3,997
| -11% | -$205K | ﹤0.01% | 837 |
|
|
2019
Q2 | $1.8M | Sell |
35,303
-22,149
| -39% | -$1.03M | ﹤0.01% | 1232 |
|
|
2019
Q1 | $2.97M | Buy |
57,452
+5,505
| +11% | +$267K | 0.01% | 839 |
|
|
2018
Q4 | $1.94M | Buy |
51,947
+19,072
| +58% | +$886K | 0.01% | 1024 |
|
|
2018
Q3 | $1.69M | Hold |
32,875
| – | – | ﹤0.01% | 1276 |
|
|
2018
Q2 | $1.54M | Hold |
32,875
| – | – | ﹤0.01% | 1344 |
|
|
2018
Q1 | $1.17M | Buy |
32,875
+400
| +1% | +$15.7K | ﹤0.01% | 1442 |
|
|
2017
Q4 | $1.42M | Hold |
32,475
| – | – | ﹤0.01% | 1376 |
|
|
2017
Q3 | $1.71M | Buy |
32,475
+150
| +0.5% | +$8.36K | ﹤0.01% | 1260 |
|
|
2017
Q2 | $1.89M | Buy |
32,325
+26,650
| +470% | +$1.38M | 0.01% | 1196 |
|
|
2017
Q1 | $259K | Hold |
5,675
| – | – | ﹤0.01% | 1858 |
|
|
2016
Q4 | $300K | Hold |
5,675
| – | – | ﹤0.01% | 1805 |
|
|
2016
Q3 | $252K | Buy |
5,675
+2,033
| +56% | +$88.2K | ﹤0.01% | 1844 |
|
|
2016
Q2 | $138K | Hold |
3,642
| – | – | ﹤0.01% | 1989 |
|
|
2016
Q1 | $150K | Buy |
3,642
+1,642
| +82% | +$67.7K | ﹤0.01% | 1494 |
|
|
2015
Q4 | $97K | Hold |
2,000
| – | – | ﹤0.01% | 1787 |
|
|
2015
Q3 | $80K | Buy |
+2,000
| New | +$87.4K | ﹤0.01% | 1857 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Canada Life's SYNH Position: Q3 2023 in Review
Canada Life sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 74,927 shares — an estimated $3.16M sold.
Canada Life first reported a position in SYNH in Q3 2015 and held it in 32 quarters. The position peaked at $5.38M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Canada Life reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Canada Life sold 74,927 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.16M.
- Canada Life first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 32 quarters.
- Canada Life's Syneos Health, Inc. Class A Common Stock position peaked at $5.38M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Canada Life's 13F filing for Q3 2023, filed 14 Nov 2023.